Dosing regimen for a selective s1p1 receptor agonist
US-2025281463-A1 · Sep 11, 2025 · US
This page is not indexed by search engines while we improve data quality.
Dingemanse Jasper patents
Dingemanse Jasper is listed as an inventor on 19 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Dingemanse Jasper |
| Total patents | 19 |
| First publication | Sep 24, 2015 |
| Latest publication | Sep 11, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Dosing regimen for a selective S1P1 receptor agonist
US-12336980-B2 · Jun 24, 2025 · US
Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
US-11834443-B2 · Dec 5, 2023 · US
Dosing regimen for a selective S1P1 receptor agonist
US-11771683-B2 · Oct 3, 2023 · US
Dosing regimen for a selective s1p1 receptor agonist
US-2023131600-A1 · Apr 27, 2023 · US
Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
US-2023002365-A1 · Jan 5, 2023 · US
Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenox
US-11390615-B2 · Jul 19, 2022 · US
Dosing regimen for a selective s1p1 receptor agonist
US-2021401811-A1 · Dec 30, 2021 · US
Dosing regimen for a selective s1p1 receptor agonist
US-2021052555-A1 · Feb 25, 2021 · US
Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
US-2021024513-A1 · Jan 28, 2021 · US
Recent patents
Latest publications not already listed above.
Dosing regimen for a selective S1P1 receptor agonist
US-10857134-B2 · Dec 8, 2020 · US
Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
US-10836754-B2 · Nov 17, 2020 · US
Dosing regimen for a selective S1P1 agonist
US-10660880-B2 · May 26, 2020 · US
Dosing regimen for a selective s1p1 receptor agonist
US-2019151292-A1 · May 23, 2019 · US
Dosing regimen for a selective S1P1 receptor agonist
US-10251867-B2 · Apr 9, 2019 · US
Dosing regimen for a selective S1P1 receptor agonist
US-10220023-B2 · Mar 5, 2019 · US
Dosing regimen for a selective s1p1 receptor agonist
US-2018147188-A9 · May 31, 2018 · US
Dosing regimen for a selective s1p1 receptor agonist
US-2017319555-A1 · Nov 9, 2017 · US
Dosing regimen for a selective s1p1 receptor agonist
US-2015265580-A1 · Sep 24, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Actelion Pharmaceuticals Ltd | 12 |
| Idorsia Pharmaceuticals Ltd | 5 |
| Vanda Pharmaceuticals Inc | 2 |
| Acetlion Pharmaceuticals Ltd | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.